Israel's ICL Q4 revenue up 6%, adjusted EBITDA climbs 10% on strong fertilizer, salt prices

Reuters
02/18
Israel's ICL Q4 revenue up 6%, adjusted EBITDA climbs 10% on strong fertilizer, salt prices 

Overview

  • Specialty minerals firm's Q4 revenue rose 6% yr/yr

  • Adjusted EBITDA for Q4 increased 10% yr/yr

  • Company acquired Bartek Ingredients and reviewed non-core assets

Outlook

  • ICL expects 2026 adjusted EBITDA between $1.4 bln and $1.6 bln

  • Company projects 2026 potash sales volumes between 4.5 mln and 4.7 mln metric tons

  • ICL plans to focus on specialty crop nutrition and food solutions for growth

Result Drivers

  • STRATEGIC ADJUSTMENTS - ICL incurred $239 mln in adjustments related to strategic changes, including discontinuing LFP battery projects and efficiency improvements

  • POTASH PRICE INCREASE - Potash prices rose 22% yr/yr, positively impacting operating income despite lower sales volumes due to adverse weather

  • PHOSPHATE PRICES - Higher selling prices of phosphate fertilizers and salts positively impacted operating income, despite higher raw material costs

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Sales

$1.70 bln

Q4 Adjusted EBITDA

$380 mln

Q4 EBIT

-$16 mln

Q4 Gross Profit

$468 mln

Analyst Coverage

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the agricultural chemicals peer group is "hold"

  • Wall Street's median 12-month price target for ICL Group Ltd is $6.08, about 5.1% above its February 17 closing price of $5.78

  • The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 15 three months ago

Press Release: ID:nBw697y2Sa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10